RETRACTED ARTICLE:MicroRNA-142-3p,a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN

Tumor Biology

Volumn 35, Issue 10, 2014, Pages 10287-10293

  Yang, Yao Qi ^a   Qi, Jin ^a   Xu, Jian Qiang ^a   Hao, Ping ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

FASN; Menin; MicroRNA MicroRNA 142 3p; Osteosarcoma

Indexed keywords

FASN PROTEIN, HUMAN; FATTY ACID SYNTHASE; MEN1 PROTEIN, HUMAN; MICRORNA; MIRN142 MICRORNA, HUMAN; ONCOPROTEIN; SMALL INTERFERING RNA;

BIOSYNTHESIS; BONE TUMOR; CELL PROLIFERATION; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; OSTEOSARCOMA; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

BLOTTING, WESTERN; BONE NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; FATTY ACID SYNTHASE, TYPE I; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; OSTEOSARCOMA; PROTO-ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84922391578     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2316-z     Document Type: TB

References (25)

1. Matkar S, Thiel A, Hua X. Menin: a scaffold protein that controls gene expression and cell signaling. Trends Biochem Sci. 2013;38(8): 394–402.
2. Yang YJ, Song TY, Park J, et al. Menin mediates epigenetic regulation via histone H3 lysine 9 methylation. Cell Death Dis. 2013;4:e583.
3. Shi K, Parekh VI, Roy S, et al. The embryonic transcription factor Hlxb9 is a menin interacting partner that controls pancreatic β-cell proliferation and the expression of insulin regulators. Endocr Relat Cancer. 2013;20(1):111–22.
4. Alvelos MI, Vinagre J, Fonseca E, et al. MEN1 intragenic deletions may represent the most prevalent somatic event in sporadic primary hyperparathyroidism. Eur J Endocrinol. 2012;168(2):119–28.
5. Gang D, Hongwei H, Hedai L, et al. The tumor suppressor protein menin inhibits NF-κB-mediated transactivation through recruitment of Sirt1 in hepatocellular carcinoma. Mol Biol Rep. 2013;40(3): 2461–6.
6. Wu Y, Feng ZJ, Gao SB, et al. Interplay between menin and K-Ras in regulating lung adenocarcinoma. J Biol Chem. 2012;287(47):40003–11.
7. Horiguchi K, Yamada M, Satoh T, et al. Transcriptional activation of the mixed lineage leukemia-p27Kip1 pathway by a somatostatin analogue. Clin Cancer Res. 2009;15(8):2620–9.
8. Veschi S, Lattanzio R, Aceto GM, et al. Alterations of MEN1 and E-cadherin/β-catenin complex in sporadic pulmonary carcinoids. Int J Oncol. 2012;41(4):1221–8.
9. Gurung B, Feng Z, Iwamoto DV, et al. Menin epigenetically represses Hedgehog signaling in MEN1 tumor syndrome. Cancer Res. 2013;73(8):2650–8.
10. Xu B, Li SH, Zheng R, et al. Menin promotes hepatocellular carci-nogenesis and epigenetically up-regulates Yap1 transcription. Proc Natl Acad Sci U S A. 2013;110(43):17480–5.
11. Gill J, Ahluwalia MK, Geller D, et al. New targets and approaches in osteosarcoma. Pharmacol Ther. 2013;137(1):89–99.
12. Han G, Wang Y, Bi W. C-Myc overexpression promotes osteosarco-ma cell invasion via activation of MEK-ERK pathway. Oncol Res. 2012;20(4):149–56.
13. Zhang P, Dong L, Yan K, et al. CXCR4-mediated osteosarcoma growth and pulmonary metastasis is promoted by mesenchymal stem cells through VEGF. Oncol Rep. 2013;30(4):1753–61.
14. Gurung B, Muhammad AB, Hua X. Menin is required for optimal processing of the microRNA let-7a. J Biol Chem. 2014;289(14): 9902–8.
15. Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet. 2012;13(4): 271–82.
16. Sun K, Lai EC. Adult-specific functions of animal microRNAs. Nat Rev Genet. 2013;14(8):535–48.
17. Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861–74.
18. Kasinski AL, Slack FJ. Epigenetics and genetics MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer. 2011;11(12): 849–64.
19. Bidard FC, Pierga JY, Soria JC, et al. Translating metastasis-related biomarkers to the clinic–progress and pitfalls. Nat Rev Clin Oncol. 2013;10(3):169–79.
20. Wu L, Cai C, Wang X, et al. MicroRNA-142-3p, a new regulator of RAC1, suppresses the migration and invasion of hepatocellular carcinoma cells. FEBS Lett. 2011;585(9):1322–30.
21. Shen WW, Zeng Z, Zhu WX, et al. MiR-142-3p functions as a tumor suppressor by targeting CD133, ABCG2, and Lgr5 in colon cancer cells. J Mol Med (Berl). 2013;91(8):989–1000.
22. Menendez JA, Lupu R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 2007;7(10):763–77.
23. Zaytseva YY, Rychahou PG, Gulhati P, et al. Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer. Cancer Res. 2012;72(6):1504–17.
24. Liu ZL, Wang G, Peng AF, et al. Fatty acid synthase expression in osteosarcoma and its correlation with pulmonary metastasis. Oncol Lett. 2012;4(5):878–82.
25. Liu ZL, Zhou Y, Luo QF, et al. Inhibition of fatty acid synthase supresses osteosarcoma cell invasion and migration. Indian J Pathol Microbiol. 2012;55(2):163–9.